Latest in News & Research
Sun Protection Misinformation Still Common
Yet, six in 10 U.S. adults give themselves high marks for sun protection
Should Basal Cell Carcinoma Management Be Based on Age?
Age was not associated with any outcome among patients aged 70 years and older with basal cell carcinoma
Does Invasive cSCC Risk Increase With Severe Actinic Keratosis Lesions?
Risk increased in patients with Olsen grade III lesions and especially for those who needed additional treatment
Annual Costs Estimated for Wart Treatment in the U.S. for 2015-2017
Per-patient costs for evaluation and management estimated at $288.28 for cutaneous warts and $431.47 for anogenital warts in 2019
Dermatopathologists Perceive Overdiagnosis of Skin Lesions
However, the perception of overdiagnosis of melanocytic skin lesions does not impact diagnosing behaviors
Do Patients With Psoriasis Have a Higher Incidence of Infections?
Incidence of any infection, severe and rare infections increased; risk higher for patients with severe versus mild psoriasis
Lifestyle Factors Are Predictive of Incident Psoriasis
Lifestyle factors predict risk independent of genetic risk; relative impact of lifestyle factors greater than genetic risk
FDA Warns 12 Companies About Skin Lightening Products
There are no FDA-approved or otherwise legally marketed over-the-counter skin lightening products
Clinical Management Guidelines Lacking for Monkeypox
Treatment guidance mainly limited to antiviral advice, vaccination recommended as postexposure prophylaxis
Inflammatory Skin Diseases Classified at Molecular Level
Molecular signatures for inflammatory skin diseases can help with classification of clinically indeterminate skin rashes
Gonorrhea, Syphilis, Congenital Syphilis Levels Up in 2020
Initial decrease across STDs reported during early part of 2020; decrease in chlamydia continued through 2020 but likely reflects underdiagnosis
Mild Psoriasis Aligns With Patient-Reported Outcome of PASS
Both Psoriasis Area and Severity Index and body surface area have limited capability for differentiating acceptable symptom state
Is Botulinum Toxin Type A Effective for Postop Cleft Lip/Palate Scars?
Review of four studies shows significant difference in terms of scar width and Visual Analog Scale for BTXA group
Does Pediatric Psoriasis Improve With Ixekizumab Treatment?
Skin condition and itch significantly improved with ixekizumab through 108 weeks, with no new safety findings from 48 to 108 weeks
Incidence of Herpes Zoster Up for >50s With COVID-19 Diagnosis
Increased herpes zoster risk found for those with versus without COVID-19, with more pronounced risk following COVID-19 hospitalization
American Academy of Dermatology, March 25 to 29
The 2022 American Academy of Dermatology Annual Meeting
AAD: Skin Videomicroscopy Biomarker May Help Predict Cancer Relapse
Incidence of melanoma thicker than 4 mm did not differ significantly for screened and unscreened patients
Primary Care-Based Screening Ups Thin Melanoma Detection
Incidence of melanoma thicker than 4 mm did not differ significantly for screened and unscreened patients
AAD: Ruxolitinib Beneficial in Nonsegmental Vitiligo
Clinically meaningful improvement reported in facial and total Vitiligo Area Scoring Index with ruxolitinib cream
AAD: Dupilumab Beneficial in Adults With Prurigo Nodularis
Significantly more dupilumab-treated patients achieved ≥4-point reduction in 24h Worst-Itch Numeric Rating Scale at weeks 12 and 24
Does Oral Vitamin D3 Improve Response to PDT in Actinic Keratoses?
Patients receiving high-dose oral vitamin D3 prior to photodynamic therapy had improved clearance rates of facial AK
AAD: Berdazimer Gel Clears Molluscum Contagiosum Lesions
Lesion reduction seen by week 4, with continuous improvement over time; treatment-emergent adverse events mainly mild
What Biologics Offer the Best Treatment Persistence for Psoriatic Disease?
Treatment persistence high with IL-17 inhibitors versus TNF inhibitors for psoriasis, psoriatic arthritis patients
24 of 1274